KEGG   PATHWAY: mpah05206
Entry
mpah05206                   Pathway                                
Name
MicroRNAs in cancer - Mus pahari (shrew mouse)
Description
MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.
Class
Human Diseases; Cancer: overview
Pathway map
mpah05206  MicroRNAs in cancer
mpah05206

Organism
Mus pahari (shrew mouse) [GN:mpah]
Gene
110312812  Pten; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
110316560  Cdkn1b; cyclin-dependent kinase inhibitor 1B [KO:K06624]
110326176  Timp3; metalloproteinase inhibitor 3 [KO:K16866]
110316221  Kras; GTPase KRas isoform X1 [KO:K07827]
110316496  Cdk6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
110327415  Cdc25a; M-phase inducer phosphatase 1 isoform X1 [KO:K06645] [EC:3.1.3.48]
110318116  Cdc25b; M-phase inducer phosphatase 2 isoform X1 [KO:K05866] [EC:3.1.3.48]
110333485  Cdc25c; LOW QUALITY PROTEIN: M-phase inducer phosphatase 3 [KO:K05867] [EC:3.1.3.48]
110326524  Hmga2; LOW QUALITY PROTEIN: high mobility group protein HMGI-C [KO:K09283]
110322378  Ccnd1; G1/S-specific cyclin-D1 [KO:K04503]
110315929  Ccnd2; G1/S-specific cyclin-D2 [KO:K10151]
110338930  Ccne2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
110324083  Ccne1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
110331717  Crk; adapter molecule crk isoform X1 [KO:K04438]
110329586  Crkl; crk-like protein isoform X1 [KO:K04438]
110322457  Hdac4; histone deacetylase 4 isoform X1 [KO:K11406] [EC:3.5.1.98]
110332270  Hdac5; histone deacetylase 5 isoform X1 [KO:K11406] [EC:3.5.1.98]
110314731  Foxp1; forkhead box protein P1 isoform X1 [KO:K23582]
110338042  Pim1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
110316104  Met; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
110324204  Dnmt3a; DNA (cytosine-5)-methyltransferase 3A isoform X1 [KO:K17398] [EC:2.1.1.37]
110318038  DNA (cytosine-5)-methyltransferase 3B [KO:K17399] [EC:2.1.1.37]
110320476  Mcl1; induced myeloid leukemia cell differentiation protein Mcl-1 isoform X1 [KO:K02539]
110325305  bcl-2-like protein 2 isoform X1 [KO:K02163]
110330480  Egfr; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
110335444  Vegfa; vascular endothelial growth factor A isoform X1 [KO:K05448]
110333013  Zeb1; zinc finger E-box-binding homeobox 1 isoform X1 [KO:K09299]
110321649  Tgfb2; transforming growth factor beta-2 isoform X1 [KO:K13376]
110338525  Ezr; ezrin isoform X1 [KO:K08007]
110313385  Pdcd4; programmed cell death protein 4 isoform X1 [KO:K16865]
110334526  Ep300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
110330048  Crebbp; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
110328220  Tpm1; tropomyosin alpha-1 chain isoform X1 [KO:K10373]
110325659  Spry2; protein sprouty homolog 2 [KO:K17383]
110321591  Bcl2; apoptosis regulator Bcl-2 [KO:K02161]
110322543  Serpinb5; serpin B5 [KO:K10139]
110327886  St14; suppressor of tumorigenicity 14 protein [KO:K08670] [EC:3.4.21.109]
110335735  cytochrome P450 1B1 [KO:K07410] [EC:1.14.14.1]
110323363  Mtor; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
110331504  Rptor; regulatory-associated protein of mTOR isoform X1 [KO:K07204]
110318266  1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X1 [KO:K07436] [EC:1.14.15.16]
110331339  Erbb2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
110326297  Erbb3; receptor tyrosine-protein kinase erbB-3 [KO:K05084] [EC:2.7.10.1]
110318646  Abl1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
110329759  Tp63; tumor protein 63 isoform X1 [KO:K10149]
110319003  Zeb2; zinc finger E-box-binding homeobox 2 isoform X1 [KO:K23560]
110312898  Fscn1; fascin [KO:K23551]
110327714  Rassf1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
110319227  Hoxd10; homeobox protein Hox-D10 [KO:K09295]
110326660  Ddit4; DNA damage-inducible transcript 4 protein [KO:K08270]
110318230  Bmf; bcl-2-modifying factor isoform X1 [KO:K17460]
110323245  Pak4; serine/threonine-protein kinase PAK 4 isoform X1 [KO:K05734] [EC:2.7.11.1]
110318332  Mmp9; matrix metalloproteinase-9 isoform X1 [KO:K01403] [EC:3.4.24.35]
110312777  Slc7a1; high affinity cationic amino acid transporter 1 [KO:K13863]
110331352  Ccng1; cyclin-G1 [KO:K10145]
110336229  Hmox1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
110322944  Stmn1; stathmin [KO:K04381]
110332765  Stat3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
110334656  Myc; myc proto-oncogene protein [KO:K04377]
110336608  Casp3; caspase-3 [KO:K02187] [EC:3.4.22.56]
110318967  GTPase HRas-like isoform X1 [KO:K02833]
110319567  Hras; GTPase HRas [KO:K02833]
110338480  GTPase HRas-like [KO:K02833]
110333346  GTPase HRas-like [KO:K02833]
110320340  Nras; GTPase NRas [KO:K07828]
110327329  Dnmt1; DNA (cytosine-5)-methyltransferase 1 isoform X1 [KO:K00558] [EC:2.1.1.37]
110333195  Apc; adenomatous polyposis coli protein isoform X1 [KO:K02085]
110326173  Apc2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
110321270  Irs1; insulin receptor substrate 1 [KO:K16172]
110328811  Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
110336420  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
110322865  Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
110331679  Mapk7; mitogen-activated protein kinase 7 isoform X1 [KO:K04464] [EC:2.7.11.24]
110323448  Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
110319750  Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
110327251  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
110333964  Hnrnpk; heterogeneous nuclear ribonucleoprotein K isoform X1 [KO:K12886]
110338772  Reck; reversion-inducing cysteine-rich protein with Kazal motifs [KO:K17461]
110333784  E2f3; transcription factor E2F3 isoform X1 [KO:K06620]
110336729  Irs2; insulin receptor substrate 2 [KO:K07187]
110318758  Notch1; neurogenic locus notch homolog protein 1 [KO:K02599]
110319730  Notch2; neurogenic locus notch homolog protein 2 [KO:K20994]
110335972  Notch3; LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 3 [KO:K20995]
110335523  Notch4; neurogenic locus notch homolog protein 4 [KO:K20996]
110317823  Bmi1; polycomb complex protein BMI-1 [KO:K11459]
110338693  Mmp16; matrix metalloproteinase-16 [KO:K07996] [EC:3.4.24.-]
110327456  Atm; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
110329809  Socs1; suppressor of cytokine signaling 1 [KO:K04694]
110317524  Cd44; CD44 antigen isoform X1 [KO:K06256]
110324857  Dicer1; endoribonuclease Dicer [KO:K11592] [EC:3.1.26.-]
110325524  Fzd3; frizzled-3 [KO:K02329]
110334621  Itga5; integrin alpha-5 isoform X1 [KO:K06484]
110327234  Rdx; radixin isoform X1 [KO:K05762]
110326378  transforming protein RhoA-like isoform X1 [KO:K04513]
110327907  Rhoa; transforming protein RhoA isoform X1 [KO:K04513]
110325641  Plau; urokinase-type plasminogen activator [KO:K01348] [EC:3.4.21.73]
110338169  Bak1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
110334783  Zfpm2; zinc finger protein ZFPM2 [KO:K17442]
110331915  Itgb3; integrin beta-3 [KO:K06493]
110338038  Ube2i; SUMO-conjugating enzyme UBC9 [KO:K10577]
110333664  Sox4; transcription factor SOX-4 [KO:K23581]
110322758  Tnc; tenascin isoform X1 [KO:K06252]
110322035  Tnn; tenascin-N [KO:K06252]
110321780  Tnr; tenascin-R isoform X1 [KO:K06252]
110335613  Tnxb; tenascin-X isoform X1 [KO:K06252]
110315904  multidrug resistance protein 1B isoform X1 [KO:K05658] [EC:7.6.2.2]
110316096  Abcb1; multidrug resistance protein 1 isoform X1 [KO:K05658] [EC:7.6.2.2]
110329472  Abcc1; multidrug resistance-associated protein 1 [KO:K05665] [EC:7.6.2.3]
110331180  Brca1; breast cancer type 1 susceptibility protein isoform X1 [KO:K10605] [EC:2.3.2.27]
110338236  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
110320485  Efna1; ephrin-A1 isoform X1 [KO:K05462]
110326602  Efna2; ephrin-A2 [KO:K05462]
110320552  Efna4; ephrin-A4 [KO:K05462]
110320381  Efna3; ephrin-A3 [KO:K05462]
110335603  Efna5; ephrin-A5 isoform X1 [KO:K05462]
110319023  Thbs1; thrombospondin-1 isoform X1 [KO:K16857]
110331592  Igf2bp1; insulin-like growth factor 2 mRNA-binding protein 1 isoform X1 [KO:K17391]
110328503  Trim71; E3 ubiquitin-protein ligase TRIM71 [KO:K12035] [EC:2.3.2.27]
110319789  Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
110336182  Ikbkb; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
110321554  Ptgs2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
110315297  prostaglandin G/H synthase 2-like [KO:K11987] [EC:1.14.99.1]
110329343  Mapk1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
110320020  Mapk3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
110332714  Prkca; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
110320075  Prkcb; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
110336366  Prkcg; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
110331195  Grb2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
110330788  Fgfr3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
110324254  Rps6ka5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
110331731  Tp53; cellular tumor antigen p53 isoform X1 [KO:K04451]
110326473  Mdm2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
110321327  Mdm4; protein Mdm4 isoform X1 [KO:K10127]
110331028  Pdgfra; platelet-derived growth factor receptor alpha isoform X1 [KO:K04363] [EC:2.7.10.1]
110319649  Plcg1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
110337392  Plcg2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
110314893  Raf1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
110327244  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
110326321  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
110335780  Sos1; son of sevenless homolog 1 [KO:K03099]
110324314  Sos2; son of sevenless homolog 2 isoform X1 [KO:K03099]
110320247  Shc1; SHC-transforming protein 1 isoform X1 [KO:K06279]
110312881  Pdgfa; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
110318126  Shc4; SHC-transforming protein 4 [KO:K17449]
110334927  Pdgfb; platelet-derived growth factor subunit B [KO:K17386]
110333065  Pdgfrb; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
110323545  cyclin-dependent kinase inhibitor 2A [KO:K06621]
110318578  E2f1; transcription factor E2F1 [KO:K17454]
110323461  E2f2; transcription factor E2F2 [KO:K09389]
110318278  Bcl2l11; bcl-2-like protein 11 isoform X1 [KO:K16341]
110326458  Marcks; myristoylated alanine-rich C-kinase substrate [KO:K12561]
110321925  Bmpr2; bone morphogenetic protein receptor type-2 [KO:K04671] [EC:2.7.11.30]
110326229  Hdac2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
110322864  Hdac1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
110315211  Ezh2; histone-lysine N-methyltransferase EZH2 isoform X1 [KO:K11430] [EC:2.1.1.356]
110326593  Gls2; glutaminase liver isoform, mitochondrial isoform X1 [KO:K01425] [EC:3.5.1.2]
110321223  Gls; glutaminase kidney isoform, mitochondrial isoform X1 [KO:K01425] [EC:3.5.1.2]
110326468  Sirt1; NAD-dependent protein deacetylase sirtuin-1 isoform X1 [KO:K11411] [EC:2.3.1.286]
110331952  Wnt3; proto-oncogene Wnt-3 [KO:K00312]
110331285  Wnt3a; protein Wnt-3a [KO:K00312]
110333773  Cdca5; sororin [KO:K17390]
110328359  Kif23; kinesin-like protein KIF23 [KO:K17387]
110333549  Rock1; rho-associated protein kinase 1 [KO:K04514] [EC:2.7.11.1]
110336160  Prkce; protein kinase C epsilon type isoform X1 [KO:K18050] [EC:2.7.11.13]
110322276  Slc45a3; solute carrier family 45 member 3 [KO:K15379]
110317616  Vim; vimentin [KO:K07606]
Reference
  Authors
Lee YS, Dutta A
  Title
MicroRNAs in cancer.
  Journal
Annu Rev Pathol 4:199-227 (2009)
DOI:10.1146/annurev.pathol.4.110807.092222
Reference
  Authors
Babashah S, Soleimani M
  Title
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
  Journal
Eur J Cancer 47:1127-37 (2011)
DOI:10.1016/j.ejca.2011.02.008
Reference
  Authors
Garzon R, Calin GA, Croce CM
  Title
MicroRNAs in Cancer.
  Journal
Annu Rev Med 60:167-79 (2009)
DOI:10.1146/annurev.med.59.053006.104707
Reference
  Authors
Chen PS, Su JL, Hung MC
  Title
Dysregulation of microRNAs in cancer.
  Journal
J Biomed Sci 19:90 (2012)
DOI:10.1186/1423-0127-19-90
Reference
  Authors
Ling H, Zhang W, Calin GA
  Title
Principles of microRNA involvement in human cancers.
  Journal
Chin J Cancer 30:739-48 (2011)
DOI:10.5732/cjc.011.10243
Reference
  Authors
Iorio MV, Croce CM
  Title
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.
  Journal
EMBO Mol Med 4:143-59 (2012)
DOI:10.1002/emmm.201100209
Reference
  Authors
Sayed D, Abdellatif M
  Title
MicroRNAs in development and disease.
  Journal
Physiol Rev 91:827-87 (2011)
DOI:10.1152/physrev.00006.2010
Reference
  Authors
Wang Q, Wang S, Wang H, Li P, Ma Z
  Title
MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
  Journal
Exp Biol Med (Maywood) 237:227-35 (2012)
DOI:10.1258/ebm.2011.011192
Reference
  Authors
Song JH, Meltzer SJ
  Title
MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
  Journal
Gastroenterology 143:35-47.e2 (2012)
DOI:10.1053/j.gastro.2012.05.003
Reference
  Authors
Chu Y, Zhu H, Lv L, Zhou Y, Huo J
  Title
MiRNA s in oesophageal squamous cancer.
  Journal
Neth J Med 71:69-75 (2013)
Reference
  Authors
Kan T, Meltzer SJ
  Title
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
  Journal
Curr Opin Pharmacol 9:727-32 (2009)
DOI:10.1016/j.coph.2009.08.009
Reference
  Authors
Smith CM, Watson DI, Michael MZ, Hussey DJ
  Title
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
  Journal
World J Gastroenterol 16:531-7 (2010)
DOI:10.3748/wjg.v16.i5.531
Reference
  Authors
Song S, Ajani JA
  Title
The role of microRNAs in cancers of the upper gastrointestinal tract.
  Journal
Nat Rev Gastroenterol Hepatol 10:109-18 (2013)
DOI:10.1038/nrgastro.2012.210
Reference
  Authors
Liu WH, Yeh SH, Chen PJ
  Title
Role of microRNAs in hepatitis B virus replication and pathogenesis.
  Journal
Biochim Biophys Acta 1809:678-85 (2011)
DOI:10.1016/j.bbagrm.2011.04.008
Reference
  Authors
Hrasovec S, Glavac D
  Title
MicroRNAs as Novel Biomarkers in Colorectal Cancer.
  Journal
Front Genet 3:180 (2012)
DOI:10.3389/fgene.2012.00180
Reference
  Authors
Liu H
  Title
MicroRNAs in breast cancer initiation and progression.
  Journal
Cell Mol Life Sci 69:3587-99 (2012)
DOI:10.1007/s00018-012-1128-9
Reference
  Authors
Li SD, Zhang JR, Wang YQ, Wan XP
  Title
The role of microRNAs in ovarian cancer initiation and progression.
  Journal
J Cell Mol Med 14:2240-9 (2010)
DOI:10.1111/j.1582-4934.2010.01058.x
Reference
  Authors
Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA
  Title
Characteristic patterns of microRNA expression in human bladder cancer.
  Journal
Front Genet 3:310 (2012)
DOI:10.3389/fgene.2012.00310
Reference
  Authors
Saini S, Majid S, Dahiya R
  Title
Diet, microRNAs and prostate cancer.
  Journal
Pharm Res 27:1014-26 (2010)
DOI:10.1007/s11095-010-0086-x
Related
pathway
mpah05210  Colorectal cancer
mpah05214  Glioma
mpah05215  Prostate cancer
mpah05219  Bladder cancer
mpah05222  Small cell lung cancer
mpah05223  Non-small cell lung cancer
KO pathway
ko05206   
LinkDB

DBGET integrated database retrieval system